NAD+ IV Therapy: How It Works, Costs & What Evidence Exists (2026)

A quick disclosure: YourHealthier sells an oral NMN supplement, not IV therapy services. We believe oral precursors offer a better evidence-to-cost ratio, but we'll present the IV data honestly so you can decide for yourself.

NAD+ IV therapy (also known as a NAD+ IV drip, NAD+ infusion, or simply NAD IV) delivers nicotinamide adenine dinucleotide directly into your bloodstream through a 2–4 hour intravenous infusion. It costs $250–$1,000 per session. No randomized controlled trials have been published on its efficacy for any indication.

Key Takeaways

NAD+ IV therapy infuses NAD+ directly into the bloodstream over 2–4 hours in a clinical setting. Cost is $250–$1,000 per session; a full initial protocol runs $1,500–$6,000. No published RCTs support NAD+ IV therapy for any indication, including addiction recovery or anti-aging. Subjective energy improvement is commonly reported but can't be separated from placebo without controlled trials. Oral NMN provides the best cost-per-evidence ratio — roughly 10–15× better than IV therapy.

🩺 Doctor's Clinical Note

Dr. Jill Palko, MD, FACOG Cleveland Clinic-Trained · Board-Certified OB/GYN NPI #1093033011 · View Credentials

"NAD+ injections can be administered at home and are absorbed within a few minutes. Once again, there is no clinical data that proves injections are superior to oral NAD+."

What Is NAD+ IV Therapy?

NAD+ IV therapy delivers 250–750 mg of nicotinamide adenine dinucleotide directly into your bloodstream over a 2–4 hour infusion at $250–$1,000 per session. It provides 100% bioavailability but has zero published RCTs for any indication.

NAD IV is one of the most-searched wellness treatments in 2026. Here's what the evidence actually shows about NAD+ IV therapy, NAD+ drip protocols, and NAD+ infusion costs — and why the clinical data may not support the price tag.

NAD+ IV therapy (also called a NAD+ drip or NAD+ infusion) is an intravenous delivery of nicotinamide adenine dinucleotide, administered in a clinical setting over 2–4 hours.

The procedure involves a slow IV drip of NAD+ dissolved in saline, typically at a specialized wellness clinic. Doses range from 250 mg to 750 mg per session. The infusion must be administered slowly because rapid NAD+ delivery causes significant flushing, chest tightness, and nausea. Effects that diminish when the drip rate is reduced.

NAD+ IV therapy isn't FDA-approved for any medical condition. It is offered under the general practice of IV vitamin therapy, which exists in a regulatory gray zone between medicine and wellness services. Eric Verdin, MD, President of the Buck Institute for Research on Aging, has noted that while the theoretical rationale for NAD+ restoration is sound, the specific value proposition of IV delivery over oral precursors hasn't been clinically established.

How Does a NAD+ IV Session Work?

A NAD+ IV session delivers 250–750 mg of NAD+ directly into a vein over 2–4 hours. The drip starts slow to limit side effects like flushing and nausea, then adjusts to tolerance. Because it bypasses digestion entirely, IV delivers 100% bioavailability — though no trial has shown this translates to better outcomes than oral NMN.

A typical session takes 2–4 hours, begins with a low drip rate, and gradually increases. Most clinics recommend an initial series of 4–6 sessions over 2 weeks.

Before the session: A brief intake assessment reviews medical history, current medications, and goals. Some clinics offer baseline blood NAD+ testing (typically $100–$200 additional).

During the infusion: The IV starts at a low drip rate to minimize side effects. If flushing or nausea occurs, the rate is slowed. You'll sit in a chair or recline. Most patients read, work on devices, or rest during the 2–4 hours.

After the session: Most patients report immediate energy and mental clarity. Though the extent to which this is pharmacological vs placebo is impossible to determine without controlled trials. Effects typically last 1–2 weeks per anecdotal reports.

NAD+ Drip Therapy: What a Full Protocol Looks Like

Most clinics structure NAD+ drip therapy as a loading series (4–6 sessions over 2 weeks) plus monthly maintenance. The claimed benefits — energy, mental clarity, cellular repair — are commonly reported but indistinguishable from placebo without controlled trials.

NAD+ drip therapy (also called a NAD+ infusion) is rarely a single session. Most clinics structure it as a protocol: an initial loading series followed by maintenance drips. A typical structure runs 4–6 sessions over two weeks for loading, then monthly maintenance infusions. Each drip delivers 250–750 mg of NAD+ over 2–4 hours.

The claimed NAD+ drip benefits are marketed by use case — energy and mental clarity for general wellness, cellular repair for anti-aging, and cravings reduction for addiction recovery. It's important to separate what's reported from what's proven. Subjective energy and clarity are commonly reported by patients, but these effects cannot be distinguished from placebo without controlled trials, and no such trials exist. The NAD+ infusion benefits that clinics advertise rest on mechanism and anecdote rather than randomized evidence. That doesn't mean people don't feel something — it means we can't attribute what they feel specifically to NAD+ versus the expectation, hydration, and rest that accompany a multi-hour clinical infusion.

How Much Does NAD+ IV Therapy Cost?

A single NAD+ IV session runs $250–$1,000, with most clinics charging $400–$600. Loading protocols of 4–6 sessions cost $1,500–$5,000, and addiction programs can reach $10,000–$25,000. Compared to oral NMN at roughly $1–$2.50 per daily dose, IV therapy is 100–400× more expensive per NAD+ delivery.

A single session costs $250–$1,000 depending on location, dose, and clinic. A full initial protocol runs $1,500–$6,000.

Insurance doesn't cover NAD+ IV therapy. Some clinics offer membership plans that reduce per-session costs by 15–30%. The daily cost of oral NMN supplementation, by comparison, is $1–$2 for equivalent or better-studied NAD+ elevation.

What Is NAD+ IV Therapy Used For?

Clinics market NAD+ IV therapy for energy, mental clarity, anti-aging, athletic recovery, and addiction treatment. None of these uses is supported by published randomized trials. The infusion reliably raises NAD+ levels, but whether that produces the marketed benefits remains unproven — reported effects can't be separated from placebo without controlled studies.

The claimed NAD IV therapy benefits (NAD+ IV therapy benefits) span addiction recovery, anti-aging, cognitive enhancement, and chronic fatigue. But clinical evidence supporting these NAD+ infusion benefits is extremely limited:

Clinics market NAD+ IV for anti-aging, chronic fatigue, addiction recovery, neurodegenerative conditions, and athletic performance. The clinical evidence for each is either preliminary or absent.

Anti-aging and longevity. NAD+ declines roughly 50% between ages 30 and 60, which is why longevity protocols target it (Massudi et al., 2012). Restoring levels is a reasonable goal. But the 2026 Christen trial showed that oral NMN and NR achieve a 2× NAD+ increase within 14 days. Whether IV delivery produces superior tissue-level restoration has not been tested. Shin-ichiro Imai, MD, PhD at Washington University has noted that tissue-specific NAD+ distribution may matter more than peak blood levels. And IV does not necessarily improve tissue delivery.

Addiction and substance abuse recovery. This is the most frequently marketed clinical use. A 2019 pilot study by Mestayer et al. documented changes in plasma and urine NAD+ during a 6-hour IV infusion protocol in people with substance use disorders — a pharmacokinetic observation, not a controlled efficacy trial. However, this was an uncontrolled, unblinded observation with no placebo arm. The lowest tier of clinical evidence. Joseph Baur, PhD at the University of Pennsylvania has noted that while NAD+'s role in neuronal repair pathways provides a plausible mechanism, the clinical evidence does not yet support the marketing claims.

Chronic fatigue. NAD+ drives mitochondrial energy production, the mechanism behind NMN's reported energy benefits (ATP synthesis via oxidative phosphorylation). Fatigue is the most commonly reported benefit by IV patients. But without placebo-controlled data, the contribution of the actual NAD+ molecule vs the placebo effect of a clinical setting + IV + $500 cost can't be separated.

Cognitive function. NAD+ supports neuronal health through sirtuin pathways (see our NMN mechanism guide). Some clinics offer "brain boost" NAD+ infusions, sometimes combined with glutathione or B-vitamin cocktails. No controlled evidence supports cognitive enhancement from NAD+ IV therapy specifically.

What Are the Side Effects and Risks of NAD+ IV Therapy?

During infusion: flushing, nausea, chest tightness, and cramping — usually eased by slowing the drip. IV-specific risks include infection, vein inflammation (phlebitis), and rare air embolism. The long-term safety of repeated high-dose NAD+ infusions has never been studied, and drug interactions with infused NAD+ are essentially unknown.

NAD+ IV therapy side effects are well-documented anecdotally but poorly studied in controlled settings. The most commonly reported NAD+ IV side effects include:

Common side effects include flushing, nausea, chest tightness, and headache during infusion. These are rate-dependent. Slowing the drip typically resolves them.

Andrea Maier, MD, PhD at the University of Melbourne has emphasized that the side effect profile of IV NAD+ delivery may differ significantly from oral precursors due to rapid peak plasma concentrations. Brad Stanfield, MD has specifically cautioned about cardiac effects — NAD+ influences cardiac electrophysiology through sirtuin and PARP pathways, and rapid IV delivery creates concentration spikes that gradual oral absorption doesn't.

Infusion-specific risks:

• Phlebitis (vein inflammation) from repeated IV access
• Infection risk at the IV site, particularly with repeated use
• Air embolism (rare, but a risk with any IV procedure)
• Allergic reaction to compounded formulation additives

NAD+ IV Before and After: What Should You Expect?

Many patients report a post-infusion 'reset' — clearer thinking, brighter mood, better sleep — in the days following a session. These effects are subjective, short-lived (1–2 weeks), and undocumented in controlled research. Infused NAD+ itself is metabolized within hours, so any lasting effect is not from circulating NAD+ remaining in the body.

Most patients report immediate energy improvement after their first session. Whether this persists beyond 1–2 weeks or is distinguishable from placebo is unknown.

The "before and after" experience reported across clinic testimonials and online forums follows a consistent pattern: noticeable energy within hours, improved mental clarity for 1–2 weeks, then gradual return to baseline. Prompting the next session. This pattern is consistent with either genuine NAD+ restoration or a classic placebo response cycle.

For evidence-based before-and-after timelines from controlled trials (using oral NMN), see our NMN before and after guide. The key difference: oral NMN trials measure objective biomarkers and functional outcomes, not subjective "how I feel" reports.

Does Insurance Cover NAD+ IV Therapy? And How Long Does It Last?

NAD+ IV therapy is almost never covered by insurance — it's classified as elective wellness, not FDA-approved treatment. Patients report effects lasting 1–2 weeks per session, but infused NAD+ itself is metabolized within hours.

Insurance coverage. NAD+ IV therapy is almost never covered by insurance. Because it is not FDA-approved for any medical indication and is classified as an elective wellness service, patients pay out of pocket. This is worth factoring into the cost calculation: at $250–$1,000 per session with no insurance offset, a full loading-plus-maintenance protocol can run $2,400–$6,000 in the first year.

How long does NAD IV last? (How long does NAD+ IV last?) There's no controlled data on how long a NAD+ IV "lasts," because the subjective effects haven't been rigorously measured. Anecdotally, patients report feeling effects for one to two weeks per session, which is why clinics recommend monthly maintenance. Physiologically, infused NAD+ is metabolized within hours; any longer-lasting subjective effect would reflect downstream changes rather than sustained blood NAD+ elevation. The mismatch between hours-long NAD+ clearance and weeks-long reported effects is one reason the placebo question looms large here.

NAD+ IV vs Injections vs Oral: Which Delivery Method?

Oral NMN/NR: cheapest, most convenient, only option with 20+ RCTs. Injections: mid-cost, 0 RCTs. IV: highest cost and single-session dose, 0 RCTs. Higher bioavailability has never been shown to produce better real-world outcomes.

All three methods aim to raise NAD+, but they differ sharply in cost, evidence, and practicality. IV therapy offers the highest single-session dose and 100% bioavailability, but at the highest cost and time commitment (2–4 hours in a clinic). Injections are more convenient and cheaper than IV, delivering NAD+ subcutaneously in minutes, but still cost far more than oral and carry the same zero-RCT evidence gap. Oral NMN and NR are the cheapest, most convenient, and by far the best-studied — the only option with published randomized controlled trials demonstrating NAD+ elevation.

The decision framework is straightforward: if you want the option backed by actual human trial evidence at the lowest cost, oral precursors win decisively. IV and injection delivery buy you higher bioavailability and, for IV, a high single dose — but neither has been shown in controlled research to translate that pharmacokinetic advantage into better real-world outcomes. For most people, the rational sequence is to start with a tested oral precursor and only consider clinical delivery methods for a specific, physician-guided reason.

Who Should Not Get NAD+ IV Therapy?

People with active or prior cancer should consult an oncologist first, since NAD+ fuels all cells. Pregnant or breastfeeding women should avoid it due to absent safety data. Those with heart rhythm conditions, on immunosuppressants or chemotherapy, or with a history of severe IV reactions should avoid NAD+ IV therapy or proceed only under close medical supervision.

Several groups should avoid NAD+ IV therapy or proceed only under physician supervision.

Heart arrhythmia or cardiac conditions. Rapid IV NAD+ delivery can affect heart rhythm. Anyone with a history of arrhythmia, heart failure, or cardiac events should avoid NAD+ IV unless cleared by a cardiologist.

Active cancer. NAD+ fuels cell proliferation. IV delivery creates higher peak concentrations than oral supplementation, potentially amplifying the theoretical cancer-promotion concern.

Kidney or liver disease. Impaired organ function may slow NAD+ clearance, leading to accumulation at unpredictable levels.

Pregnancy or breastfeeding. Zero safety data exists for NAD+ IV during pregnancy.

Needle phobia or poor venous access. A 2–4 hour IV infusion requires stable venous access; patients with difficult veins may experience repeated needle sticks.

Why We Recommend Trying Oral NMN First

We sell an oral NMN supplement.

We sell an oral NMN supplement. Full disclosure. But the recommendation to start with oral precursors is not commercially motivated, it's evidence-motivated: 12+ published RCTs support oral NMN at $1–$2/day, vs zero published RCTs for NAD+ IV at $250–$1,000/session. If you've tried oral NMN at 500 mg/day for 8–12 weeks without noticeable improvement, NAD+ IV therapy may be worth exploring as a higher-bioavailability option. But you should go into it understanding the evidence gap.

Our Analysis: NAD+ IV Therapy Annual Cost vs Alternatives

We calculated the total annual cost of common NAD+ delivery methods at typical maintenance protocols:

Our analysis: oral NMN provides the best cost-per-evidence ratio by a factor of 10–15×. The question is not whether NAD+ IV therapy might work. The question is whether it works $5,000–$11,000/year better than oral NMN. No published evidence supports that premium.

NAD+ IV Therapy for Addiction: The Most-Marketed Claim

Addiction recovery is the single most prominent marketing claim for NAD+ IV therapy. Clinics advertise 10-day NAD+ IV protocols for opioid, alcohol, and stimulant addiction at $10,000–$25,000 per program. The clinical evidence behind these claims consists of one small open-label study and decades of anecdotal clinic reports — not the kind of proof that justifies that price tag.

The origin story: NAD+ IV therapy for addiction dates to the work of Dr. Richard Mestayer in Springfield, Louisiana, who has treated thousands of patients with NAD+ infusions since the early 2000s. His clinic's published pilot data (Mestayer et al., 2019) documented measurable NAD+ changes in plasma and urine during a 6-hour infusion protocol. But it was a small, uncontrolled pharmacokinetic study — it measured whether infused NAD+ shows up in the body, not whether it improves addiction outcomes. Reports of reduced cravings from this clinic remain anecdotal, with no control group, placebo comparison, or blinding to separate any effect from the therapeutic setting (rest, clinical attention, removal from triggering environments).

The mechanism is at least plausible: chronic substance use depletes brain NAD+ and damages mitochondrial function in reward-pathway neurons. Restoring NAD+ could theoretically accelerate neuronal recovery. But plausibility is not proof. Medication-assisted treatment (buprenorphine, naltrexone for opioids; naltrexone, acamprosate for alcohol) has been validated in hundreds of randomized trials. NAD+ IV therapy has not. Anyone considering NAD+ IV for addiction should view it as an unproven adjunct, not a replacement for evidence-based addiction medicine.

NAD+ IV Therapy Reviews: What Patients Report

Patient reviews of NAD+ IV therapy cluster around a consistent narrative: the infusion itself is uncomfortable (flushing, nausea, chest pressure that eases when the drip rate is slowed), but many describe a noticeable energy and clarity "reset" in the days following. Negative reviews emphasize cost, time commitment, and skepticism about whether the effect is worth the price versus oral alternatives.

A few patterns worth noting from aggregated reviews:

• The infusion experience itself is often described as unpleasant. The 2–4 hour duration, the initial nausea, and the need to sit still frustrate many first-time patients. Most say it gets easier by the second or third session.
• The post-infusion "glow" is commonly reported. Descriptions like "clearer thinking," "brighter mood," and "better sleep the first night" appear frequently. These are subjective and impossible to verify, but they are consistent enough to suggest patients perceive something — the question is whether that something is pharmacological or placebo.
• Long-term value is where reviews diverge. Some people become regular monthly users and credit NAD+ IV with sustained wellness improvements. Others try one course, perceive modest or no benefit, and conclude it's not worth the cost compared to oral precursors.
• The comparison to oral NMN appears frequently in honest reviews. Users who have tried both often conclude that oral NMN provides 60–80% of the perceived benefit at 5–10% of the cost — making IV therapy hard to justify as a routine protocol for most people.

NAD+ IV Therapy Safety: A Deeper Look at Risks

Beyond the commonly reported side effects (flushing, nausea, chest tightness), NAD+ IV therapy carries risks inherent to any IV procedure that patients should understand before booking a session.

IV-specific risks:

• Infection. Any IV insertion creates a path for bacteria to enter the bloodstream. Reputable clinics use sterile technique, but the risk is nonzero and increases at facilities that prioritize throughput over protocol.
• Phlebitis. Inflammation of the vein at the insertion site, causing pain, redness, and swelling. More common with longer infusions (3–4 hours) and repeat sessions in the same vein.
• Air embolism. Rare but possible with any IV line if air enters the tubing. This is a procedural risk managed by trained staff — another reason clinical setting matters.
• Electrolyte shifts. Rapid NAD+ infusion can transiently affect heart rhythm in sensitive individuals. This is why reputable clinics start at low drip rates and monitor patients.

NAD+-specific unknowns:

• The long-term safety of repeated high-dose NAD+ infusions has never been studied. Monthly infusions of 500 mg+ NAD+ for years is an experiment with n=1 — you.
• The cancer question applies here as well: chronically elevated NAD+ could theoretically fuel both healthy and malignant cells. No clinical evidence shows harm, but the question is scientifically unresolved.
• Drug interactions with NAD+ infusions are essentially unstudied. If you take blood pressure medications, immunosuppressants, or chemotherapy agents, the interaction profile is unknown.

How to Find a Reputable NAD+ IV Therapy Clinic

If you decide to try NAD+ IV therapy despite the evidence limitations, clinic quality varies dramatically. The difference between a well-run medical practice and a strip-mall IV lounge can affect both safety and outcomes.

Green flags (what to look for):

• A licensed physician (MD or DO) oversees the practice and is available during infusions — not just a nurse practitioner working independently.
• NAD+ is sourced from a licensed, inspected compounding pharmacy with certificates of analysis for potency and sterility.
• The clinic conducts a medical intake including health history, current medications, and blood pressure check before the first infusion.
• Staff are trained in IV administration and emergency response. An IV adverse reaction protocol should be visible or available on request.
• Transparent pricing with no high-pressure upselling of extended packages before you've tried a single session.

Red flags (walk away):

• No physician involvement — a "wellness lounge" with no medical license or oversight.
• Unable or unwilling to disclose the compounding pharmacy source or provide a COA for the NAD+ used.
• Pressure to commit to a $5,000–$15,000 multi-session package upfront before experiencing even one infusion.
• Claims that NAD+ IV "cures" specific diseases — this is both scientifically unsupported and a regulatory violation.

NAD+ IV Therapy: What Happens Session by Session?

Session 1 is the longest and least comfortable as the drip rate is tested. Sessions 2–4 (loading): side effects ease and responders begin noticing energy and clarity. Sessions 5–6 complete the loading phase — those feeling nothing by now rarely benefit from more. Monthly maintenance is a single infusion, where cost-effectiveness versus oral NMN becomes the key question.

Session 1: Expect the longest and most uncomfortable session. The drip starts slow to assess tolerance. Flushing, warmth in the chest, and mild nausea are common in the first 30–60 minutes and typically ease as the body adjusts. Total time: 3–4 hours including setup. Most people report feeling tired or "wired" the evening of the first infusion.

Sessions 2–4 (loading): Side effects generally decrease. The drip rate can usually be increased slightly. Many patients report the energy and clarity effects beginning after the second session. Some clinics space these every other day; others do daily sessions during the loading phase.

Sessions 5–6 (completing the loading phase): By this point, patients who will respond have generally noticed improvement. Those who feel nothing after 6 sessions are unlikely to benefit from additional infusions — a responsible clinic will acknowledge this rather than recommending more.

Monthly maintenance: A single infusion every 4–6 weeks to sustain NAD+ levels. This is the phase where cost-effectiveness becomes the central question: is one $500 infusion per month delivering more than $50/month of oral NMN? For most people, the controlled trial data says no — but individual perception varies.

Frequently Asked Questions

Is NAD+ IV therapy worth the cost?

Based on current evidence, it's hard to justify. Oral NMN achieves a 2× NAD+ increase at $30–$60/month (Christen 2026). NAD+ IV costs $250–$1,000/session with zero published RCTs. The cost-evidence ratio strongly favors oral supplementation.

How long does NAD+ IV therapy last?

Anecdotal reports suggest subjective effects last 1–2 weeks per session. NAD+ has a circulating half-life of minutes to hours (see how oral NMN timing works differently), so the sustained effects likely reflect tissue-level changes rather than blood levels. But this hasn't been clinically measured for IV-delivered NAD+.

What does NAD+ IV therapy feel like?

Most patients report warmth, flushing, and sometimes nausea during infusion (especially at higher drip rates), followed by a sense of energy and mental clarity after the session. These subjective experiences haven't been separated from placebo effects in controlled settings.

Can NAD+ IV therapy help with addiction?

One uncontrolled 2019 pilot study (Mestayer et al.) measured NAD+ changes during infusion but did not establish clinical benefit. This is the lowest tier of clinical evidence. No randomized trial has tested this. The mechanism is plausible but unproven — the same caution applies to all NAD+ marketing claims.

Is NAD+ IV therapy safe?

Common side effects (flushing, nausea, chest tightness) are manageable by adjusting drip rate. Serious risks include cardiac effects, phlebitis, and infection. Without published safety trials, the complete risk profile is unknown.

How often should you get NAD+ IV therapy?

Clinic protocols vary from weekly during initial loading to monthly for maintenance. These aren't evidence-based frequencies. They're derived from clinical practice without trial validation.

Where can I find NAD+ IV therapy near me?

Search "NAD IV therapy near me" or "NAD+ IV therapy near me" or "NAD+ infusion near me" to locate clinics in your area. NAD+ IV therapy is typically offered at IV hydration lounges, wellness clinics, functional medicine offices, and some concierge medical practices. Pricing and protocols vary significantly between providers. Before booking, confirm the clinic uses pharmaceutical-grade NAD+ from a licensed compounding pharmacy, has a licensed medical provider on-site during infusions, and can provide certificates of analysis for their NAD+ supply.

Is taking NAD orally effective?

Yes — oral NAD+ precursors (NMN and NR) are proven effective at raising blood NAD+ levels, with 20+ human trials confirming this. Oral NAD+ itself is poorly absorbed, which is why supplements use precursors instead. The common claim that oral NAD+ "doesn't work" and you need IV or injections confuses direct NAD+ (poorly absorbed) with NMN/NR precursors (well absorbed and clinically validated).

Related Reading

• NAD+ supplements: complete guide
• NAD+ injections: benefits, costs, and evidence
• What is NMN?
• NMN vs NAD: what's the difference?
• NMN dosage guide
• NMN before and after
• Best NMN supplements
• NMN side effects
• Longevity supplements
• NMN and resveratrol stack

Authoritative Resources

For independent, government-reviewed information on NAD+ and IV therapy, consult these primary sources:

• NIH Office of Dietary Supplements — Niacin (NAD+ precursor)
• NCCIH — Complementary Health Approaches

Our Batch-Level Purity Testing

Manufactured in a facility operating in compliance with FDA current Good Manufacturing Practices (21 CFR Part 111). Every batch of NMN (Nicotinamide Mononucleotide, 250 mg) undergoes independent third-party testing at an ISO/IEC 17025–accredited laboratory for purity, heavy metals, and microbial contamination. Lot YH-NMN-2025-09 passed every safety threshold.

Analytical methods: heavy metals via ICP-MS; microbiology per USP methods. The data below reflects batch-specific results — not general ingredient claims — verified under current Good Manufacturing Practices (21 CFR Part 111).

Testing performed by ISO/IEC 17025–accredited laboratory. Serving size: 1 capsule (250 mg NMN). Full batch results: yourhealthier.com/pages/lab-results. Original certificates of analysis available upon request.

Testing & Transparency Methodology

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories (ISO/IEC 17025). Each batch is screened for heavy metals (lead, cadmium, mercury, arsenic) and microbial contamination using validated USP and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results and updated with each new manufacturing run. All testing complies with current Good Manufacturing Practices (21 CFR Part 111). This article is written for general educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

References

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

NAD+ IV Therapy: Cost and Evidence

Metric	Value
Cost per session	$250-$1,000
Session duration	2-4 hours
Initial protocol cost	$1,500-$6,000
Published RCTs	0
Oral NMN annual cost	$365-$730
IV annual cost (monthly)	$3,000-$12,000
Source: Clinic pricing survey; Christen 2026 for oral comparison

Chart: NAD+ IV vs Oral — Cost per Session. Data: Oral NMN $1-2.50; Injections $50-150; IV therapy $250-1,000. Oral is 10-15x cheaper per dose.